Development

  • DCU Research Team Meeting 2025

    , , , ,

    PBC Biomed were delighted to meet with the research team at Dublin City University (DCU) last week to review and refine our collaborative plans for the years ahead. Our collaboration with DCU remains a key driver in our mission to enhance patient wellness, with their expertise playing a vital role in strengthening the research arm…

    Read More...

  • PBC Biomed receive special recognition award from Sports Ireland Institute for AFN contribution

    , ,

    Earlier this month, we were honoured to receive a Special Recognition Award from the Sport Ireland Institute for our participation in the Athlete Friendly Employer Network programme. We are proud to contribute to this initiative, which helps Ireland’s elite athletes manage the dual demands of sport and career. By providing flexible and supportive opportunities, we…

    Read More...

  • PBC Biomed Poster Presentation at ESB 2025

    , , , , ,

    Congratulations to Senior R&D Engineer Antzela Tzagiollari on her poster presentation at the ESB 2025 event yesterday, highlighting her team’s research on OsStic® as a promising next-generation biomaterial. Their findings show that OsStic® uniquely combines bone adhesion, mechanical strength, and prolonged antibiotic delivery. While incorporating vancomycin reduced its strength, OsStic® still demonstrated clinically acceptable performance.…

    Read More...

  • PBC Biomed expertise on OCP Manufacturing & Research – Learn more at ESB 2025

    , , , ,

    PBC Biomed is internationally recognised for its expertise in the manufacturing and research of Octa-calcium Phosphate (OCP), as well as in the advancement of innovative biomedical technologies. Our team will be on booth #20 during the #ESB meeting next week to provide insights into our ongoing research initiatives, development programmes, and future technological advancements. We…

    Read More...

  • European Society for Biomaterials Meeting 2025

    , , , ,

    The countdown is on for this year’s European Society For Biomaterials – ESB Meeting in Turin! We’re excited to be part of this year’s event and invite you to visit us at booth #20 next week. Our team will be on hand to share updates on our ongoing development programmes and research initiatives. Looking ahead,…

    Read More...

  • Kicking Off a New Partnership with Colorado State University’s Translational Medicine Institute

    , , ,

    Kicking Off a New Partnership with Colorado State University’s Translational Medicine Institute Chief Medical Officer Dr Russell, R&D Director Paul Dorrell, R&D Engineer Antzela Tzagiollari are just back from a successful trip to the C. Wayne Mcilwraith Translational Medicine Institute in Colorado. Colorado State University’s Translational Medicine Institute is a state-of-the-art research hub which brings…

    Read More...

  • OssiVet® Now Available in EU

    , ,

    OssiVet® Now Available in EU We’re excited to announce that OssiVet®, our innovative Synthetic Adhesive Bone Substitute, is now available for use in domestic companion animals for orthopedic reduction, provisional fixation, and void filling of bone fractures or defects. OssiVet® is designed to make a difference in your practice by offering: • Simplified application for…

    Read More...

  • PBC and friends get together for a group photo in a lab in the University of Leeds

    Innovation Lab at University of Leeds

    , ,

    Innovation Lab at University of Leeds Last week the PBC Biomed team held their first innovation lab of the year in the University of Leeds Teaching Hospital. Our Clinical Advisory Board – Dr Hassan Mir, MD, MBA, Dr John Tracy Watson and Dr Thomas A. (Toney) Russell MD and our host Professor Peter Giannoudis, were…

    Read More...

  • Biomimetic Innovations Ltd Announces Exclusive License and Distribution Agreement with Sanara MedTech Inc

    , ,

    We are proud to announce that our affiliate partner Biomimetic Innovations Limited(BMI), has announced the execution of an exclusive license and distribution agreement with Sanara MedTech Inc. Sanara agreed to invest in BMI with cash for equity at the same time. Sanara, a medical technology company based in Fort Worth, Texas, with attention to developing…

    Read More...

  • Happy New Year from all of us at PBC Biomed Group!

    ,

    Our mission of ‘Enhancing Patient Wellness’ continues to drive us and will be central to all our activities in 2025. Providing clinical solutions in both Human and Veterinary through our newly released products, *ReFeel® Nerve Repair Solution, HANIA Skin Protectant and OssiVet (Bioadhesive) will be key focus areas, while we continue to work with our…

    Read More...